GPX4 and hepatocellular carcinoma: Ferroptosis-targeting drugs, drug combination applications, nanotechnology, etc., act to induce ferroptosis in HCC mainly through System xc−/GSH/GPX4, iron metabolism, p53, and lipid peroxidation pathways.